Guangdong Marubi Biotechnology Co., Ltd. (SHA:603983)
China flag China · Delayed Price · Currency is CNY
32.55
-0.45 (-1.36%)
At close: Feb 6, 2026

SHA:603983 Balance Sheet

Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year
TTMFY 2024FY 2023FY 2022FY 2021FY 2020
Period Ending
Sep '25 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20
Cash & Equivalents
1,5922,0321,0771,073806.11,670
Short-Term Investments
53.3544.08279.64333.41115.15-
Trading Asset Securities
412.62395.7767.98437.78738.09820.58
Cash & Short-Term Investments
2,0582,4722,1241,8441,6592,490
Cash Growth
-1.93%16.36%15.19%11.14%-33.37%-14.05%
Accounts Receivable
22.146.4331.573.9362.855.22
Other Receivables
12.4611.5714.647.437.423.56
Receivables
34.565846.1481.3670.268.78
Inventory
281.37219.66171.73151.7138.43138.3
Prepaid Expenses
----4.91.7
Other Current Assets
220.25204.83187.75159.99102.8842.45
Total Current Assets
2,5942,9542,5302,2371,9762,682
Property, Plant & Equipment
1,0181,082769.91520.59384.14246.02
Long-Term Investments
226.22165.6663.6173.8775.1249.89
Other Intangible Assets
688.49699.16719.58748.63764.5618.63
Long-Term Deferred Tax Assets
90.4191.8559.142.1621.6730.59
Long-Term Deferred Charges
7.981.743.172.589.9821.25
Other Long-Term Assets
220.9767.96308.41469.07530.38747
Total Assets
4,8475,0634,4544,0943,7623,795
Accounts Payable
210.97253.14178.15152.94154.46203.13
Accrued Expenses
26.15167.8156.78156.8104.95107.22
Short-Term Debt
572.99790.1100.07100-106.7
Current Portion of Long-Term Debt
--148.12.1--
Current Portion of Leases
1.062.364.058.654.79-
Current Income Taxes Payable
29.6432.6715.4527.9824.7636.82
Current Unearned Revenue
176.37195.12240.494.53144.57227.78
Other Current Liabilities
419.65155.34167.19125.47143.02104.98
Total Current Liabilities
1,4371,5971,010668.47576.55786.64
Long-Term Debt
---148--
Long-Term Leases
1.931.53.2511.6814.68-
Long-Term Unearned Revenue
4.755.396.165.569.515.83
Long-Term Deferred Tax Liabilities
11.8312.2615.237.852.451.97
Other Long-Term Liabilities
-0.360.36---
Total Liabilities
1,4551,6161,035841.56603.19794.44
Common Stock
401401401401.44401.82401
Additional Paid-In Capital
761761760.45774.49780.12754.29
Retained Earnings
2,1632,2202,1872,0281,9301,823
Treasury Stock
----14.47-26.66-
Comprehensive Income & Other
-1.78-1.71-1.58-1.49-1.28-0.29
Total Common Equity
3,3233,3803,3473,1883,0842,978
Minority Interest
67.8166.171.4264.5174.3622.9
Shareholders' Equity
3,3913,4473,4193,2533,1583,001
Total Liabilities & Equity
4,8475,0634,4544,0943,7623,795
Total Debt
575.98793.97255.48270.4419.47106.7
Net Cash (Debt)
1,4821,6781,8691,5741,6402,384
Net Cash Growth
-19.69%-10.22%18.75%-4.03%-31.21%-17.73%
Net Cash Per Share
3.674.174.683.894.105.95
Filing Date Shares Outstanding
401401401401.44401.82401
Total Common Shares Outstanding
401401401401.44401.82401
Working Capital
1,1571,3581,5201,5691,3991,895
Book Value Per Share
8.298.438.357.947.687.43
Tangible Book Value
2,6352,6812,6282,4392,3202,959
Tangible Book Value Per Share
6.576.696.556.085.777.38
Buildings
-507.12476.51274.43274.43267.01
Machinery
-93.0485.3973.5263.4653.97
Construction In Progress
-603.06309.48253.24118.622.03
Source: S&P Global Market Intelligence. Standard template. Financial Sources.